. Author manuscript; available in PMC: 2018 May 1.

Published in final edited form as: J Allergy Clin Immunol Pract. 2016 Nov 30;5(3):764–770. doi: 10.1016/j.jaip.2016.09.046

Table II.

Asthma Morbidity (N=175)

	N (%) or mean (SD)
Uncontrolled over last 4 weeks using EPR3 Guidelines⁵	121 (69.1)
Uncontrolled Daytime Symptoms	61 (34.90)
Uncontrolled Nighttime Symptoms	94 (53.7)
Excess Quick relief Medication Use	60 (34.5)
Missed Activity	48 (27.6)
Control Test over last 4 weeks
Childhood Asthma Control Test (ACT) score⁴⁷ (n=73)	21 (4.1)
ACT score uncontrolled (>19)	46 (63.0)
Asthma Therapy Assessment Questionnaire (ATAQ) score⁴⁶ (n=99)	3.5 (1.8)
ATAQ score uncontrolled (≥1)	97 (98.0)
Over last 12 months
Any Emergency Department Visit	67 (38.2)
Any Hospitalization	16 (9.1)
Any Prednisone Use	64 (36.6)
Uncontrolled for any measure^*	157 (89.7)

This sums the subjects who demonstrated lack of control in any category measured: NHLBI questions, ACT or ATAQ score, or who had an emergency department visit, hospitalization or prednisone use over the last 12 months.